Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2891 of 3330
Next
>>
>
72251 to 72275 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	26.7	uM	10818.144	0.6887	-0.0641	0.4912
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	133	uM	10818.144	0.0151	-0.9996	0.4912
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.000341	uM	12126.144	0.9221	0.7612	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.00171	uM	12126.144	0.9029	0.7040	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.00853	uM	12126.144	0.9061	0.7136	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.0427	uM	12126.144	0.8235	0.4750	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.213	uM	12126.144	0.7804	0.3557	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	1.07	uM	12126.144	0.7748	0.3406	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	5.33	uM	12126.144	0.7757	0.3430	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	26.7	uM	12126.144	0.8007	0.4116	0.6379
MDA-MB-175-VII	HR+	Luminal	Temsirolimus	MTOR	MTOR	133	uM	12126.144	0.0170	-0.9966	0.6379
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.000341	uM	10643.144	0.8309	0.5450	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.00171	uM	10643.144	0.7135	0.2495	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.00853	uM	10643.144	0.6166	0.0198	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.0427	uM	10643.144	0.7155	0.2545	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.213	uM	10643.144	0.6520	0.1021	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	1.07	uM	10643.144	0.6498	0.0969	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	5.33	uM	10643.144	0.5786	-0.0667	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	26.7	uM	10643.144	0.5367	-0.1596	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	133	uM	10643.144	0.0046	-0.9989	0.7178
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.000341	uM	10999.144	0.9669	0.9045	0.6880
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.00171	uM	10999.144	0.9658	0.9013	0.6880
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.00853	uM	10999.144	0.9363	0.8176	0.6880
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.0427	uM	10999.144	0.8350	0.5388	0.6880
MDA-MB-361	HER2amp	Luminal	Temsirolimus	MTOR	MTOR	0.213	uM	10999.144	0.7680	0.3626	0.6880

|<
<<
Previous
Page 2891 of 3330
Next
>>
>
72251 to 72275 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)